Enhancing Linkage to Hepatitis C Virus Treatment Following Pregnancy in Women Identified During Perinatal Care

被引:14
|
作者
Epstein, Rachel L. [1 ,2 ]
Moloney, Carole [2 ]
Garfinkel, Jacob [3 ]
Saia, Kelley [4 ]
Wachman, Elisha M. [5 ]
Lodi, Sara [6 ]
Pelton, Stephen I. [2 ]
机构
[1] Boston Univ, Sch Med, Dept Med, Sect Infect Dis, 801 Massachusetts Ave,Crosstown Bldg,2nd Floor, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Pediat, Sect Infect Dis, Boston, MA 02118 USA
[3] Boston Univ, Sch Publ Hlth, Boston, MA USA
[4] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA
[5] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA
[6] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA
关键词
UNITED-STATES; OPIOID USE; DELIVERY HOSPITALIZATION; INFECTION; RECOMMENDATIONS; CASCADE; COHORT;
D O I
10.1002/hep4.1748
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Amid the current US opioid crisis, hepatitis C virus (HCV) infection rates continue to rise in young adults, including among pregnant women, yet few studies describe linkage to care and treatment in pregnant or postpartum women with HCV infection. We used electronic health record data to estimate HCV treatment rates for postpartum women before (January 2014-September 2016) and during (October 2016-March 2018) implementation of a maternal-infant HCV linkage program in combination with a multidisciplinary clinic to colocate mother and infant care. Using Poisson regression models, we compared HCV treatment initiation rates, adjusting for demographics, substance use, and treatment. From January 2014 through March 2018, 343 women who were HCV seropositive delivered at our institution. Of these, 95% completed HCV nucleic acid testing and 255 women had chronic HCV infection. Mean age was 30 years, 96% were publicly insured, and 94% had documented substance use. HCV treatment initiation increased from 28/164 (17.1%) women with chronic HCV infection in the preintervention period to 16/66 (24.2%) with the linkage-only intervention and 13/25 (52.0%) with the linkage intervention and colocated care. Adjusted analyses demonstrated that women delivering during the intervention period initiated HCV treatment at 2.40 times (95% confidence interval [CI], 1.10-5.25; linkage only) and 3.36 times (95% CI, 1.57-7.17; linkage and colocated care) the rate of women delivering preintervention. Women on buprenorphine had higher HCV treatment initiation rates compared with those on methadone (rate ratio, 2.10; 95% CI, 1.05-4.21). Conclusion: HCV linkage to care and treatment rates improved in the setting of mother-infant linkage and colocated care interventions. Perinatal care may represent a critical venue to identify, link, and treat women for HCV infection to improve their own health and prevent transmission to subsequent pregnancies.
引用
收藏
页码:1543 / 1554
页数:12
相关论文
共 50 条
  • [1] CHARACTERIZING LINKAGE TO HEPATITIS C VIRUS CARE DURING AND FOLLOWING PREGNANCY: IDENTIFYING MISSED OPPORTUNITIES FOR TESTING AND TREATMENT
    Mendlowitz, Andrew Bryan
    Flemming, Jennifer A.
    Kushner, Tatyana
    Wong, William W. L.
    Greenwald, Zoe R.
    Kwong, Jeff
    Capraru, Camelia
    Feld, Jordan J.
    Biondi, Mia
    [J]. HEPATOLOGY, 2023, 78 : S58 - S59
  • [2] Perspectives of women receiving treatment for hepatitis c virus during pregnancy
    Kislovskiy, Y.
    Chang, J.
    Flaherty, E.
    Hamm, M. E.
    Cameron, F. de Abril
    Krans, E. E.
    Chappell, C. A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (06) : 970 - 971
  • [3] Best practices for hepatitis C linkage to care in pregnant and postpartum women: perspectives from the Treatment In Pregnancy for Hepatitis C Community of Practice
    Gupta, Neil
    Hiebert, Lindsey
    Saseetharran, Ankeeta
    Chappell, Catherine
    El-Sayed, Manal H.
    Hamid, Saeed
    Jhaveri, Ravi
    Judd, Ali
    Kushner, Tatyana
    Badell, Martina
    Biondi, Mia
    Buresh, Megan
    Prasad, Mona
    Price, Jennifer C.
    Ward, John W.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (04) : 377 - 385
  • [4] ENHANCING HEPATITIS C AND HIV SCREENING AND LINKAGE TO TREATMENT IN PRIMARY CARE PRACTICE
    Karliner, Leah S.
    Kobashi, Brent
    Kuryan, Chiara
    Lam, Rosemary
    Fox, Rena K.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2017, 32 : S748 - S748
  • [5] Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection
    van Zonneveld, M
    van Nunen, AB
    Niesters, HGM
    de Man, RA
    Schalm, SW
    Janssen, HLA
    [J]. JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) : 294 - 297
  • [6] The Hepatitis C Virus Care Continuum: Linkage to Hepatitis C Virus Care and Treatment Among Patients at an Urban Health Network, Philadelphia, PA
    Coyle, Catelyn
    Moorman, Anne C.
    Bartholomew, Tyler
    Klein, Gary
    Kwakwa, Helena
    Mehta, Shruti H.
    Holtzman, Deborah
    [J]. HEPATOLOGY, 2019, 70 (02) : 476 - 486
  • [8] Linkage to Care Outcomes for Hepatitis C Cases Identified in the Emergency Department
    Franco, Ricardo A.
    Overton, Edgar T.
    Tamhane, Ashutosh
    Forsythe, Jordan M.
    Rodgers, Joel B.
    Guthrie, Deanne
    Thogaripally, Suneetha
    Zinski, Anne
    Saag, Michael
    Mugavero, Michael
    Galbraith, James W.
    [J]. HEPATOLOGY, 2015, 62 : 1088A - 1088A
  • [9] Evaluating Women's Preferences for Hepatitis C Treatment During Pregnancy
    Kushner, Tatyana
    Cohen, Jennifer
    Tien, Phyllis C.
    Terrault, Norah A.
    [J]. HEPATOLOGY COMMUNICATIONS, 2018, 2 (11) : 1306 - 1310
  • [10] Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.
    van Zonneveld, M
    van Nunen, AB
    Niesters, HGM
    de Man, RA
    Schalm, SW
    Janssen, HLA
    [J]. HEPATOLOGY, 2003, 38 (04) : 707A - 707A